Product image of Zevalin (Ibritumomab Tiuxetan) supplied by GNH India

Zevalin

Active Ingredient:
Ibritumomab Tiuxetan
Origin:
EU

Zevalin (Ibritumomab Tiuxetan)

Zevalin (ibritumomab tiuxetan) is an intravenous therapy designed for targeted treatment of certain blood cancers. It combines a monoclonal antibody with a radioactive isotope for precise cancer cell targeting. Suitable for patients requiring radioimmunotherapy. Short version: Zevalin ibritumomab tiuxetan radioimmunotherapy for blood cancer treatment.

Manufacturer / TM Owner

Ceft Biopharma S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zevalin (ibritumomab tiuxetan) is primarily used to treat types of non-Hodgkin lymphoma, including relapsed or refractory cases. It is indicated for patients who have not responded adequately to other therapies. The drug targets CD20-positive B-cell lymphoma cells using a radioactive component. Patients often ask, what is Zevalin used for in cancer treatment.

Side Effects

  • As a radioimmunotherapy agent, Zevalin delivers radiation directly to cancerous B-cells while sparing healthy tissue. Common effects may include temporary reductions in blood cell counts due to bone marrow impact. Some patients experience mild fatigue or nausea during treatment. Effects vary and should be discussed with a healthcare provider.

Precautions & Warnings

  • Zevalin requires careful handling due to its radioactive properties; administration must be performed by trained professionals in a controlled setting. Patients should inform their provider of all current medications and medical conditions before treatment. Pregnant or breastfeeding individuals should avoid use. Regular blood monitoring is typically required during therapy.

Avoid Interactions

  • Zevalin may interact with other drugs affecting bone marrow function or those metabolized by liver enzymes. Live vaccines should be avoided during and after treatment. Blood transfusions may require special timing due to potential interference. Patients on immunosuppressive therapy should discuss risks with their doctor. Alcohol use may exacerbate side effects.

Frequently Asked Questions

Zevalin is used to treat certain types of non-Hodgkin lymphoma, including relapsed or refractory cases.

Zevalin is given as an intravenous infusion in a clinical setting by healthcare professionals.

Zevalin is not recommended for use during pregnancy due to potential risks to the fetus.

Common effects may include reduced blood cell counts, fatigue, or nausea; discuss any concerns with your provider.

Zevalin may interact with drugs affecting bone marrow or liver enzymes; consult your doctor before combining therapies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ibritumomab Tiuxetan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT